Director, Global Value and Health Economics, Outcomes Research

🕒 il y a 6 jours

🔔 Pennsylvania – Distant

🔔 Pennsylvania – Remote

💵 $212 000 - $318 000 / an

⏰ Temps Plein

🔴 Expert

👔 Directeur

🦅 Parrain de Visa H1B

Cette entreprise a parrainé des visas H1B par le passé.

👻 Score fantôme 0%

Ce que ça veut dire : la probabilité que personne ne recrute vraiment pour cette offre.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Jazz Pharmaceuticals

Site WebLinkedInTous les Emplois

1001 - 5000 employés

Fondée en 2003

🏥 Santé

🏭 Fabrication

🧬 Biotechnologie

Healthcare • Manufacturing • Biotechnology

Jazz Pharmaceuticals est une entreprise biopharmaceutique dédiée au développement de médicaments innovants répondant à des besoins médicaux sérieux non satisfaits. Avec un fort engagement envers la recherche et le développement, Jazz se concentre sur la création de thérapies transformatrices, mettant en avant l'importance de la collaboration, de la diversité et de l'engagement des employés dans ses opérations. L'entreprise est fière de transformer la vie des patients grâce à ses offres de produits significatives et une culture qui favorise l'enthousiasme et la flexibilité.

Description

• Lead global and US payer evidence strategy across marketed assets in Jazz’s neurology portfolio • Maximize brand potential, defend value, secure expanded access, and drive post-launch evidence generation • Develop evidence strategies for label expansions, new formulations, line extensions, and expanded patient subpopulations • Partner with Medical Affairs, Clinical Development, and Biostatistics on Phase 3b/4, pragmatic, and expanded access studies • Lead rare disease registries, natural history extensions, and post-authorization safety/efficacy studies • Design comparative effectiveness, adherence, burden-of-illness, and real-world data studies • Co-create HTA reassessment strategies and analytical packages with EU/INT HEOR teams • Direct updates to Global Value Dossiers, systematic literature reviews, and meta-analyses • Lead AMCP dossiers, unbranded value summaries, and state Medicaid submission dossiers • Design and train teams on interactive economic models and reactive scientific presentations • Ensure US HEOR materials comply with FDAMA Section 114, the 21st Century Cures Act, and FDA HCEI guidance • Evaluate outcomes-based risk-sharing agreements and real-world endpoint tracking frameworks • Monitor US health policy, ICER, and value framework developments • Formulate and execute cost-effectiveness, cost-utility, budget impact, and cost-offset modeling strategies • Build and adapt economic models using mature clinical and real-world data • Serve as GVHEOR representative in IEGP governance and align evidence initiatives with brand objectives • Partner with Market Access and cross-functional teams on post-launch evidence initiatives • Lead publications, manuscripts, and conference presentations • Manage budgets, external HEOR consultancies, academic partners, and CROs • Provide mentorship and technical guidance to evidence and value generation staff

🎯 Exigences

• Master’s degree (MSc, MS, MPH) or PhD in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Extensive experience designing and executing post-marketing HEOR strategies, real-world comparative effectiveness studies, and evidence roadmaps supporting label expansions, line extensions, and value defense • Comprehensive knowledge of the US managed care landscape and global HTA environments • Proven technical expertise building, adapting, and validating economic models, including Markov, partitioned survival, microsimulation, and dynamic budget impact models • Proven track record collaborating with US Market Access, Pricing/Contracting, and Payer Field Teams to develop compliant customer-facing tools, interactive budget models, and AMCP dossiers • Demonstrated understanding of rare disease post-launch evidence challenges • Working knowledge of major US and global healthcare databases and advanced epidemiological methods • Demonstrated ability to work with regional HEOR teams, especially EU/INT • Ability to balance evidence strategy with hands-on execution of complex technical deliverables • Exceptional verbal, written, and presentation skills; ability to influence cross-functional teams and defend methodologies • Experience with neurology assets preferred • Track record leading HEOR strategy and evidence deliverables for marketed pharmaceutical products • Launch lead for at least 2 assets as US HEOR lead, or country-level HTA lead • Experience conducting post-marketing RWE, patient registry studies, and economic evaluations • Strong peer-reviewed publication record in health economics and outcomes research

🏖️ Avantages

• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV